Andre C Kalil

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 36

Top Topics

Coronavirus Disease

Top Venues

Intensive care medicine

Open forum infectious diseases

Journal of comparative effectiveness research

Infectious diseases and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Andre C Kalil, Vishnudas Sarda, Celine Der-Torossian, Thomas F Oppelt, Mark C Berry, Alpesh N Amin
Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study. Journal of comparative effectiveness research 13 (4) (2024)
Essy Mozaffari, Aastha Chandak, Chidinma Chima-Melton, Andre C Kalil, Heng Jiang, EunYoung Lee, Celine Der-Torossian, Mark Thrun, Mark C Berry, Richard H Haubrich, Robert L Gottlieb
Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen. Open forum infectious diseases 11 (6) (2024)
Paula Fernandes, Luís Coelho, José Pedro Cidade, Adrián Ceccato, Andrew Conway Morris, Jorge Ibrahin Figueira Salluh, Vandack Nobre, Saad Nseir, Ignacio Martín-Loeches, Thiago Costa Lisboa, Paula Ramirez, Anahita Rouzé, Daniel A Sweeney, Andre C Kalil
Biomarkers in pulmonary infections: a clinical approach. Annals of intensive care 14 (1) (2024)
Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Mark Berry, Thomas Oppelt, Jason F Okulicz, Alpesh N Amin, Tobias Welte, Paul E Sax, Andre C Kalil
Lower mortality risk associated with remdesivir + dexamethasone versus dexamethasone alone for the treatment of patients hospitalized for COVID-19. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Andre C Kalil, Vishnudas Sarda, Celine Der-Torossian, Thomas F Oppelt, Mark C Berry, Alpesh N Amin
Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study. Journal of comparative effectiveness research 13 (4) (2024)
Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Andre C Kalil, Vishnudas Sarda, Celine Der-Torossian, Thomas F Oppelt, Mark C Berry, Alpesh N Amin
Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study. Journal of comparative effectiveness research 13 (4) (2024)
Paula Fernandes, Luís Coelho, José Pedro Cidade, Adrián Ceccato, Andrew Conway Morris, Jorge Ibrahin Figueira Salluh, Vandack Nobre, Saad Nseir, Ignacio Martín-Loeches, Thiago Costa Lisboa, Paula Ramirez, Anahita Rouzé, Daniel A Sweeney, Andre C Kalil
Biomarkers in pulmonary infections: a clinical approach. Annals of intensive care 14 (1) (2024)
Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Andre C Kalil, Vishnudas Sarda, Celine Der-Torossian, Thomas F Oppelt, Mark C Berry, Alpesh N Amin
Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study. Journal of comparative effectiveness research (2024)
Robert L Gottlieb, Andre C Kalil
True DisCoVeRy of COVID-19 Disease Burden Versus Speculated Antiviral Cardiovascular Risk Requires a Control Group. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Andre C Kalil, Vishnudas Sarda, Celine Der-Torossian, Thomas F Oppelt, Mark C Berry, Alpesh N Amin
Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study. Journal of comparative effectiveness research 13 (4) (2024)
Essy Mozaffari, Aastha Chandak, Chidinma Chima-Melton, Andre C Kalil, Heng Jiang, EunYoung Lee, Celine Der-Torossian, Mark Thrun, Mark C Berry, Richard H Haubrich, Robert L Gottlieb
Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen. Open forum infectious diseases 11 (6) (2024)
Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Andre C Kalil, Vishnudas Sarda, Celine Der-Torossian, Thomas F Oppelt, Mark C Berry, Alpesh N Amin
Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study. Journal of comparative effectiveness research 13 (4) (2024)
Robert L Gottlieb, Andre C Kalil
True DisCoVeRy of COVID-19 Disease Burden Versus Speculated Antiviral Cardiovascular Risk Requires a Control Group. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 79 (2) (2024)
Paula Fernandes, Luís Coelho, José Pedro Cidade, Adrián Ceccato, Andrew Conway Morris, Jorge Ibrahin Figueira Salluh, Vandack Nobre, Saad Nseir, Ignacio Martín-Loeches, Thiago Costa Lisboa, Paula Ramirez, Anahita Rouzé, Daniel A Sweeney, Andre C Kalil
Biomarkers in pulmonary infections: a clinical approach. Annals of intensive care 14 (1) (2024)
Paula Fernandes, Luís Coelho, Felipe Dal Pizzol, Ricard Ferrer, Angela Huttner, Andrew Conway Morris, Vandack Nobre, Paula Ramirez, Anahita Rouzé, Jorge Ibrahin Figueira Salluh, Mervyn Singer, Daniel A Sweeney, Antoní Torres, Grant W. Waterer, Andre C Kalil
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive care medicine 49 (2) (2023)
Beatriz Arns, Jaqueline Driemeyer Correia Horvath, Gabriela Soares Rech, Guilhermo Prates Sesin, Crepin Aziz Jose Oluwafoumi Agani, Bruna Silveira da Rosa, Tiago Marcon Dos Santos, Liliane Spencer Bittencourt Brochier, Alexandre Biasi Cavalcanti, Bruno Martins Tomazini, Adriano Pereira Paglia, Viviane Cordeiro Veiga, Giovana Marssola Nascimento, Andre C Kalil, Alexandre Prehn Zavascki
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol. Infectious diseases and therapy (2023)
Ana M Ortega-Villa, Noreen A Hynes, Corri B Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg, Jing Wang, Jennifer A Whitaker, Christopher J Colombo, Seema U Nayak, Hannah Jang Kim, Nicole M Iovine, Dilek Ince, Stuart H Cohen, Adam J Langer, Jonathan M Wortham, Robert L Atmar, Hana M El Sahly, Mamta K Jain, Aneesh K Mehta, Cameron R Wolfe, Carlos A Gomez, Tatiana Beresnev, Richard A Mularski, Catharine I Paules, Andre C Kalil, Angela R Branche, Annie Luetkemeyer, Barry S Zingman, Jocelyn Voell, Michael Whitaker, Michelle S Harkins, Richard T Davey, Robert Grossberg, Sarah L George, Victor Tapson, William R Short, Varduhi Ghazaryan, Constance A Benson, Lori E Dodd, Daniel A Sweeney, Kay M Tomashek
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case. Open forum infectious diseases 10 (6) (2023)
Ana M Ortega-Villa, Noreen A Hynes, Corri B Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg, Jing Wang, Jennifer A Whitaker, Christopher J Colombo, Seema U Nayak, Hannah Jang Kim, Nicole M Iovine, Dilek Ince, Stuart H Cohen, Adam J Langer, Jonathan M Wortham, Robert L Atmar, Hana M El Sahly, Mamta K Jain, Aneesh K Mehta, Cameron R Wolfe, Carlos A Gomez, Tatiana Beresnev, Richard A Mularski, Catharine I Paules, Andre C Kalil, Angela R Branche, Annie Luetkemeyer, Barry S Zingman, Jocelyn Voell, Michael Whitaker, Michelle S Harkins, Richard T Davey, Robert Grossberg, Sarah L George, Victor Tapson, William R Short, Varduhi Ghazaryan, Constance A Benson, Lori E Dodd, Daniel A Sweeney, Kay M Tomashek
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case. Open forum infectious diseases 10 (6) (2023)
Paula Fernandes, Luís Coelho, Felipe Dal Pizzol, Ricard Ferrer, Angela Huttner, Andrew Conway Morris, Vandack Nobre, Paula Ramirez, Anahita Rouzé, Jorge Ibrahin Figueira Salluh, Mervyn Singer, Daniel A Sweeney, Antoní Torres, Grant W. Waterer, Andre C Kalil
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive care medicine (2023)
Beatriz Arns, Jaqueline Driemeyer Correia Horvath, Gabriela Soares Rech, Guilhermo Prates Sesin, Crepin Aziz Jose Oluwafoumi Agani, Bruna Silveira da Rosa, Tiago Marcon Dos Santos, Liliane Spencer Bittencourt Brochier, Alexandre Biasi Cavalcanti, Bruno Martins Tomazini, Adriano Pereira Paglia, Viviane Cordeiro Veiga, Giovana Marssola Nascimento, Andre C Kalil, Alexandre Prehn Zavascki
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol. Infectious diseases and therapy 13 (1) (2023)
Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Stephanie H Read, Heng Jiang, Mel Chiang, EunYoung Lee, Rikisha Gupta, Mark Berry, Andre C Kalil
Remdesivir reduced mortality in immunocompromised patients hospitalized for COVID-19 across variant waves: Findings from routine clinical practice. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Ana M Ortega-Villa, Noreen A Hynes, Corri B Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg, Jing Wang, Jennifer A Whitaker, Christopher J Colombo, Seema U Nayak, Hannah Jang Kim, Nicole M Iovine, Dilek Ince, Stuart H Cohen, Adam J Langer, Jonathan M Wortham, Robert L Atmar, Hana M El Sahly, Mamta K Jain, Aneesh K Mehta, Cameron R Wolfe, Carlos A Gomez, Tatiana Beresnev, Richard A Mularski, Catharine I Paules, Andre C Kalil, Angela R Branche, Annie Luetkemeyer, Barry S Zingman, Jocelyn Voell, Michael Whitaker, Michelle S Harkins, Richard T Davey, Robert Grossberg, Sarah L George, Victor Tapson, William R Short, Varduhi Ghazaryan, Constance A Benson, Lori E Dodd, Daniel A Sweeney, Kay M Tomashek
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case. Open forum infectious diseases 10 (6) (2023)
Paula Fernandes, Luís Coelho, Felipe Dal Pizzol, Ricard Ferrer, Angela Huttner, Andrew Conway Morris, Vandack Nobre, Paula Ramirez, Anahita Rouzé, Jorge Ibrahin Figueira Salluh, Mervyn Singer, Daniel A Sweeney, Antoní Torres, Grant W. Waterer, Andre C Kalil
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive care medicine (2023)
Ana M Ortega-Villa, Noreen A Hynes, Corri B Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg, Jing Wang, Jennifer A Whitaker, Christopher J Colombo, Seema U Nayak, Hannah Jang Kim, Nicole M Iovine, Dilek Ince, Stuart H Cohen, Adam J Langer, Jonathan M Wortham, Robert L Atmar, Hana M El Sahly, Mamta K Jain, Aneesh K Mehta, Cameron R Wolfe, Carlos A Gomez, Tatiana Beresnev, Richard A Mularski, Catharine I Paules, Andre C Kalil, Angela R Branche, Annie Luetkemeyer, Barry S Zingman, Jocelyn Voell, Michael Whitaker, Michelle S Harkins, Richard T Davey, Robert Grossberg, Sarah L George, Victor Tapson, William R Short, Varduhi Ghazaryan, Constance A Benson, Lori E Dodd, Daniel A Sweeney, Kay M Tomashek
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case. Open forum infectious diseases 10 (6) (2023)
Paula Fernandes, Luís Coelho, Felipe Dal Pizzol, Ricard Ferrer, Angela Huttner, Andrew Conway Morris, Vandack Nobre, Paula Ramirez, Anahita Rouzé, Jorge Ibrahin Figueira Salluh, Mervyn Singer, Daniel A Sweeney, Antoní Torres, Grant W. Waterer, Andre C Kalil
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive care medicine 49 (2) (2023)
Paula Fernandes, Luís Coelho, Felipe Dal Pizzol, Ricard Ferrer, Angela Huttner, Andrew Conway Morris, Vandack Nobre, Paula Ramirez, Anahita Rouzé, Jorge Ibrahin Figueira Salluh, Mervyn Singer, Daniel A Sweeney, Antoní Torres, Grant W. Waterer, Andre C Kalil
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive care medicine 49 (2) (2023)
Paula Fernandes, Luís Coelho, Felipe Dal Pizzol, Ricard Ferrer, Angela Huttner, Andrew Conway Morris, Vandack Nobre, Paula Ramirez, Anahita Rouzé, Jorge Ibrahin Figueira Salluh, Mervyn Singer, Daniel A Sweeney, Antoní Torres, Grant W. Waterer, Andre C Kalil
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive care medicine (2023)
Beatriz Arns, Jaqueline Driemeyer Correia Horvath, Gabriela Soares Rech, Guilhermo Prates Sesin, Crepin Aziz Jose Oluwafoumi Agani, Bruna Silveira da Rosa, Tiago Marcon Dos Santos, Liliane Spencer Bittencourt Brochier, Alexandre Biasi Cavalcanti, Bruno Martins Tomazini, Adriano Pereira Paglia, Viviane Cordeiro Veiga, Giovana Marssola Nascimento, Andre C Kalil, Alexandre Prehn Zavascki
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol. Infectious diseases and therapy 13 (1) (2023)
Paula Fernandes, Luís Coelho, Felipe Dal Pizzol, Ricard Ferrer, Angela Huttner, Andrew Conway Morris, Vandack Nobre, Paula Ramirez, Anahita Rouzé, Jorge Ibrahin Figueira Salluh, Mervyn Singer, Daniel A Sweeney, Antoní Torres, Grant W. Waterer, Andre C Kalil
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive care medicine 49 (2) (2023)
Beatriz Arns, Jaqueline Driemeyer Correia Horvath, Gabriela Soares Rech, Guilhermo Prates Sesin, Crepin Aziz Jose Oluwafoumi Agani, Bruna Silveira da Rosa, Tiago Marcon Dos Santos, Liliane Spencer Bittencourt Brochier, Alexandre Biasi Cavalcanti, Bruno Martins Tomazini, Adriano Pereira Paglia, Viviane Cordeiro Veiga, Giovana Marssola Nascimento, Andre C Kalil, Alexandre Prehn Zavascki
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol. Infectious diseases and therapy 13 (1) (2023)
Beatriz Arns, Jaqueline Driemeyer Correia Horvath, Gabriela Soares Rech, Guilhermo Prates Sesin, Crepin Aziz Jose Oluwafoumi Agani, Bruna Silveira da Rosa, Tiago Marcon Dos Santos, Liliane Spencer Bittencourt Brochier, Alexandre Biasi Cavalcanti, Bruno Martins Tomazini, Adriano Pereira Paglia, Viviane Cordeiro Veiga, Giovana Marssola Nascimento, Andre C Kalil, Alexandre Prehn Zavascki
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol. Infectious diseases and therapy 13 (1) (2023)
Andre C Kalil, Diana F Florescu
Mortality in solid organ transplant recipients hospitalized for COVID-19. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2021)
John H Beigel, Kay M Tomashek, Lori E Dodd, Aneesh K Mehta, Barry S Zingman, Andre C Kalil, Elizabeth Hohmann, Helen Y Chu, Annie Luetkemeyer, Susan Kline, Diego Lopez de Castilla, Robert W Finberg, Kerry Dierberg, Victor Tapson, Lanny Hsieh, Thomas F Patterson, Roger Paredes, Daniel A Sweeney, William R Short, Giota Touloumi, David Chien Boon Lye, Norio Ohmagari, Myoung-Don Oh, Guillermo M Ruiz-Palacios, Thomas Benfield, Gerd Fätkenheuer, Mark G Kortepeter, Robert L Atmar, C Buddy Creech, Jens Lundgren, Abdel G Babiker, Sarah Pett, James D Neaton, Timothy H Burgess, Tyler Bonnett, Michelle Green, Mat Makowski, Anu Osinusi, Seema Nayak, Henry Clifford Lane, null null
Remdesivir for the Treatment of Covid-19 - Final Report. The New England journal of medicine 383 (19) (2020)
Andre C Kalil, Thomas F Patterson, Aneesh K Mehta, Kay M Tomashek, Cameron R Wolfe, Varduhi Ghazaryan, Vincent C Marconi, Guillermo M Ruiz-Palacios, Lanny Hsieh, Susan Kline, Victor Tapson, Nicole M Iovine, Mamta K Jain, Daniel A Sweeney, Hana M El Sahly, Angela R Branche, Justino Regalado Pineda, David C Lye, Uriel Sandkovsky, Anne F Luetkemeyer, Stuart H Cohen, Robert W Finberg, Patrick E H Jackson, Babafemi Taiwo, Catharine I Paules, Henry Arguinchona, Nathaniel Erdmann, Neera Ahuja, Maria Frank, Myoung-don Oh, Eu-Suk Kim, Seow Yen Tan, Richard A Mularski, Henrik Nielsen, Philip O Ponce, Barbara S Taylor, LuAnn Larson, Nadine G Rouphael, Youssef Saklawi, Valeria D Cantos, Emily R Ko, John J Engemann, Alpesh N Amin, Miki Watanabe, Joanne Billings, Marie-Carmelle Elie, Richard T Davey, Timothy H Burgess, Jennifer Ferreira, Michelle Green, Mat Makowski, Anabela Cardoso, Stephanie de Bono, Tyler Bonnett, Michael Proschan, Gregory A Deye, Walla Dempsey, Seema U Nayak, Lori E Dodd, John H Beigel, null null
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. The New England journal of medicine 384 (9) (2020)
Andre C Kalil, Paul G Thomas
Influenza virus-related critical illness: pathophysiology and epidemiology. Critical care (London, England) 23 (1) (2019)
Daniel A Sweeney, Andre C Kalil
Didn't inhale? Time to reconsider aerosolized antibiotics in the treatment of ventilator-associated pneumonia. Critical care (London, England) 22 (1) (2018)